Related Experiment Video
Updated: Dec 30, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Impact of Continuous Flow Left Ventricular Assist Device Therapy on Chronic Kidney Disease: A Longitudinal
Yunus C Yalcin1, Rahatullah Muslem1, Kevin M Veen2
1Thoraxcenter, Unit Heart Failure, Transplantation and Mechanical Circulatory Support, Department of Cardiology, University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Cardiothoracic Surgery, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Insights
Left ventricular assist device (LVAD) implantation initially improves chronic kidney disease (CKD) in patients. However, kidney function eventually returns to baseline, though early improvement correlates with better survival rates.
Area of Science:
- Cardiology
- Nephrology
- Medical Devices
Background:
- Many patients with chronic kidney disease (CKD) undergo left ventricular assist device (LVAD) implantation.
- The impact of LVAD support on CKD progression requires investigation.
Purpose of the Study:
- To investigate the effect of LVAD support on patients with pre-existing chronic kidney disease (CKD).
Main Methods:
- A retrospective multicenter cohort study involving 400 patients implanted with LVADs (HeartMate II, HeartMate 3, HeartWare).
- Patients were stratified by CKD stage and followed for 2 years with serum creatinine measurements.
- Analysis included assessment of kidney function changes and survival rates.
Main Results:
- Pre-implantation CKD stages ranged from 1 to 5.
- LVAD implantation initially improved kidney function across all CKD stages.
- Estimated glomerular filtration rates regressed to baseline values post-improvement.
- Early renal function improvement was associated with younger patients, worse preoperative condition, and higher survival rates (69% vs. 56%).
Conclusions:
- Renal function after LVAD implantation shows an initial improvement, followed by a steady state, and subsequent deterioration.
- Patients exhibiting early renal function improvement, despite worse preoperative condition, demonstrated significantly higher 2-year survival rates.
Background:
Many patients undergoing durable left ventricular assist device (LVAD) implantation suffer from chronic kidney disease (CKD). Therefore, we investigated the effect of LVAD support on CKD.
Methods:
A retrospective multicenter cohort study, including all patients undergoing LVAD (HeartMate II (n = 330), HeartMate 3 (n = 22) and HeartWare (n = 48) implantation. In total, 227 (56.8%) patients were implanted as bridge-to-transplantation; 154 (38.5%) as destination therapy; and 19 (4.7%) as bridge-to-decision. Serum creatinine measurements were collected over a 2-year follow-up period. Patients were stratified based on CKD stage.
Results:
Overall, 400 patients (mean age 53 ± 14 years, 75% male) were included: 186 (46.5%) patients had CKD stage 1 or 2; 93 (23.3%) had CKD stage 3a; 82 (20.5%) had CKD stage 3b; and 39 (9.8%) had CKD stage 4 or 5 prior to LVAD implantation. During a median follow-up of 179 days (IQR 28-627), 32,629 creatinine measurements were available. Improvement of kidney function was noticed in every preoperative CKD-stage group. Following this improvement, estimated glomerular filtration rates regressed to baseline values for all CKD stages. Patients showing early renal function improvement were younger and in worse preoperative condition. Moreover, survival rates were higher in patients showing early improvement (69% vs 56%, log-rank P = 0 .013).
Conclusions:
Renal function following LVAD implantation is characterized by improvement, steady state and subsequent deterioration. Patients who showed early renal function improvement were in worse preoperative condition, however, and had higher survival rates at 2 years of follow-up.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations